Recombinant Human CXCR2 Protein，His & GST

CXCR2, a chemokine receptor belonging to the G protein-coupled receptor family, plays a crucial role in the immune response by mediating the recruitment of neutrophils and other immune cells to sites of inflammation. Its involvement in various pathological processes, including cancer metastasis, chronic inflammatory diseases, and autoimmune disorders, has made CXCR2 a significant target for therapeutic interventions. Research has demonstrated that the activation of CXCR2 can lead to various cellular responses, such as chemotaxis, proliferation, and survival, highlighting its importance in both normal immune function and pathological conditions. The development of CXCR2 recombinant proteins has enabled scientists to explore its structure-function relationships, signaling pathways, and interactions with ligands like IL-8 and other chemokines. These studies are essential for understanding the receptor's role in disease mechanisms and for designing novel CXCR2-targeted therapies. Additionally, CXCR2 recombinant proteins can be utilized in drug screening assays, allowing for the identification of small molecules or antibodies that can modulate its activity. As the field of immunology continues to evolve, the characterization of CXCR2 and its related pathways remains a pivotal area of research aimed at developing innovative treatments for inflammatory diseases and cancer. Overall, the advancement of recombinant technology allows for a deeper exploration of CXCR2, providing insights that could lead to significant breakthroughs in therapeutic strategies.